Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTCB02-1 vs NTCB-C in Parenteral Nutrition
NCT06625957Phase 3Recruiting
- Sponsor
- Yuhan
- Start
- Dec 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of NTCB02-1 in Malnutrition (2 arms), sponsored by Yuhan. Primary endpoint: Occurrence rate of adverse drug reaction. Started Dec 2024; status: recruiting.
02
Drugs
NTCB02-1
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT06625957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06625957.